CRSP
Price
$46.70
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
4.1B
43 days until earnings call
OLMA
Price
$4.62
Change
+$0.06 (+1.32%)
Updated
Jun 27 closing price
Capitalization
316.79M
44 days until earnings call
Interact to see
Advertisement

CRSP vs OLMA

Header iconCRSP vs OLMA Comparison
Open Charts CRSP vs OLMABanner chart's image
CRISPR Therapeutics AG
Price$46.70
Change-$0.00 (-0.00%)
Volume$32.88K
Capitalization4.1B
Olema Pharmaceuticals
Price$4.62
Change+$0.06 (+1.32%)
Volume$3.46M
Capitalization316.79M
CRSP vs OLMA Comparison Chart in %
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. OLMA commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Buy and OLMA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CRSP: $46.70 vs. OLMA: $4.62)
Brand notoriety: CRSP and OLMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 1% vs. OLMA: 393%
Market capitalization -- CRSP: $4.1B vs. OLMA: $316.79M
CRSP [@Biotechnology] is valued at $4.1B. OLMA’s [@Biotechnology] market capitalization is $316.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileOLMA’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • OLMA’s FA Score: 1 green, 4 red.
According to our system of comparison, OLMA is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 6 TA indicator(s) are bullish while OLMA’s TA Score has 3 bullish TA indicator(s).

  • CRSP’s TA Score: 6 bullish, 4 bearish.
  • OLMA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than OLMA.

Price Growth

CRSP (@Biotechnology) experienced а +5.54% price change this week, while OLMA (@Biotechnology) price change was +11.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CRSP is expected to report earnings on Aug 11, 2025.

OLMA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.1B) has a higher market cap than OLMA($317M). CRSP YTD gains are higher at: 18.648 vs. OLMA (-20.755). OLMA has higher annual earnings (EBITDA): -142.36M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. OLMA (393M). OLMA has less debt than CRSP: OLMA (1.15M) vs CRSP (219M). CRSP has higher revenues than OLMA: CRSP (35M) vs OLMA (0).
CRSPOLMACRSP / OLMA
Capitalization4.1B317M1,294%
EBITDA-455.24M-142.36M320%
Gain YTD18.648-20.755-90%
P/E RatioN/AN/A-
Revenue35M0-
Total Cash1.86B393M472%
Total Debt219M1.15M19,077%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPOLMA
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
84%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OLMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORFDF0.05N/A
+6.34%
ORECAP INVEST CORP.
IFNNY41.650.03
+0.07%
Infineon Technologies AG
NNCHY31.30N/A
N/A
Nissan Chemical Corporation
JELCF2.70N/A
N/A
Johnson Electric Holdings Ltd.
ZPHRF0.05N/A
N/A
ZEPHYR ENERGY PLC.

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
N/A
BEAM - CRSP
72%
Closely correlated
-1.98%
RXRX - CRSP
71%
Closely correlated
-6.85%
NTLA - CRSP
66%
Loosely correlated
-0.52%
ALLO - CRSP
62%
Loosely correlated
-1.67%
CRBU - CRSP
62%
Loosely correlated
-5.19%
More

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with ATXS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+1.32%
ATXS - OLMA
46%
Loosely correlated
N/A
DNLI - OLMA
46%
Loosely correlated
-2.69%
CRSP - OLMA
46%
Loosely correlated
N/A
BEAM - OLMA
46%
Loosely correlated
-1.98%
REPL - OLMA
45%
Loosely correlated
N/A
More